Poster 57
- Kelley Tangredi
- Apr 23, 2024
- 1 min read
Updated: Jun 27, 2024
The 40-gene expression profile (40-GEP) test identifies cutaneous squamous cell carcinoma (cSCC) patients at high risk of metastasis within lower-staged tumors to better guide treatment decisions
Authors: Ally-Khan Somani, Sherrif F. Ibrahim, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Javier Cañueto, and Sarah T. Arron
Poster 57